Houlihan Lokey, Inc. (HLI) · Oct 28, 2026 · Earnings

Houlihan Lokey earnings beat as M&A rebounds, restructuring lags

Beat — GAAP EPS $1.64 vs ~$1.63 consensus; revenue $692M vs ~$625.9M consensus

Houlihan Lokey earnings beat revenue expectations as Corporate Finance recovered, though fewer closed deals and weaker restructuring temper the quarter.

Houlihan Lokey is a global investment bank building around three cyclical advisory engines: M&A and capital markets, financial restructuring, and valuation and financial advisory. Its standing story entering this quarter was a recovery in M&A activity alongside persistent uncertainty from rates, geopolitics, trade policy, and leverage; the company has also described restructuring demand as stable but uneven.

The quarter beat expectations decisively on revenue. Revenue reached $692 million versus $660 million a year earlier, well above the published consensus of roughly $625.9 million, while GAAP diluted EPS was $1.64 versus roughly $1.63 expected. Adjusted EPS was $1.85 versus $1.84 a year earlier. (Financial Highlights; Reconciliation of GAAP to Adjusted Financial Information) The beat is especially meaningful after the prior quarter's earnings miss, although the exact consensus benchmark is an external estimate.

MetricQ2 FY2027Q2 FY2026 / expectationRead-through
Revenue$692M$660M prior year; ~$625.9M consensusLarge beat (Financial Highlights)
GAAP diluted EPS$1.64$1.63 prior year; ~$1.63 consensusNarrow beat (Financial Highlights)
Adjusted diluted EPS$1.85$1.84 prior yearEssentially flat year over year (Reconciliation of GAAP to Adjusted Financial Information)
Corporate Finance revenue$481M$439M prior year+10% (Segment results — Corporate Finance)
Financial Restructuring revenue$118M$134M prior year-12% (Segment results — Financial Restructuring)
FVA revenue$93M$87M prior year+7% (Segment results — Financial and Valuation Advisory)
Six-month revenue$1.203B$1.265B prior yearStill down 5% year to date (Financial Highlights)
Quarterly dividend$0.70/share$0.70 declaredNo change (Capital returns)

M&A is carrying the recovery, but the quality of the rebound is mixed. Corporate Finance revenue rose 10% because average fees increased with transaction mix and better M&A and capital-markets conditions, even as closed transactions fell to 142 from 171. 〔0〕 (Segment results — Corporate Finance) That means the quarter's revenue upside came more from larger or richer assignments than from a broad increase in deal volume. The company's 267 Corporate Finance managing directors, up from 242, also show that capacity has been added ahead of a fuller transaction recovery. (Segment results — Corporate Finance)

Restructuring remains the drag on the broader business. Financial Restructuring revenue declined 12%, with closed transactions falling to 27 from 37, while the six-month segment decline was even steeper at 10%. Management attributes the quarterly drop to closing timing, so this is not necessarily a structural deterioration, but it keeps the recovery uneven rather than broad-based. 〔1〕 (Segment results — Financial Restructuring)

Profitability held up better than the headline mix suggests. GAAP operating income increased modestly to $154 million from $151 million, while the adjusted compensation ratio stayed at 61.5%. However, adjusted non-compensation expense rose to 13.3% of revenue from 12.5%, and the six-month adjusted operating income was $272 million versus $310 million a year earlier. This is a revenue beat, not yet a clean acceleration in underlying earnings power. (Expense analysis; Reconciliation of GAAP to Adjusted Financial Information)

Capital returns remain intact despite lower year-to-date cash. The company declared its regular $0.70 quarterly dividend and repurchased 397,000 shares during the quarter; cash and investment securities totaled $888 million at September 30, 2026. (Capital returns) This supports the financial position but is a continuation of the existing policy, not a new catalyst.

Bottom line: This was a clear revenue beat and a useful confirmation that M&A conditions are improving, but the recovery still depends on fee mix and larger assignments while restructuring remains soft. The business story improved this quarter, though the six-month numbers show it is not yet a broad-based earnings acceleration.

Original filing on SEC EDGAR

More Houlihan Lokey, Inc. news

Houlihan Lokey earnings beat as M&A rebounds, restructuring lags | HLI Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.